Author:
Peng Yue,Li Yixi,Zhang Wei,ShangGuan Yu,Xie Ting,Wang Kang,Qiu Jing,Pu Wenjun,Hu Biying,Zhang Xinzhou,Yin Lianghong,Tang Donge,Dai Yong
Abstract
Abstract
Background
End-stage renal disease (ESRD) is the final stage of chronic kidney disease (CKD). In addition to the structurally intact chromosome genomic DNA, there is a double-stranded circular DNA called extrachromosomal circular DNA (eccDNA), which is thought to be involved in the epigenetic regulation of human disease. However, the features of eccDNA in ESRD patients are barely known. In this study, we identified eccDNA from ESRD patients and healthy people, as well as revealed the characteristics of eccDNA in patients with ESRD.
Methods
Using the high-throughput Circle-Sequencing technique, we examined the eccDNA in peripheral blood mononuclear cells (PBMCs) from healthy people (NC) (n = 12) and ESRD patients (n = 16). We analyzed the length distribution, genome elements, and motifs feature of eccDNA in ESRD patients. Then, after identifying the specific eccDNA in ESRD patients, we explored the potential functions of the target genes of the specific eccDNA. Finally, we investigated the probable hub eccDNA using algorithms.
Results
In total, 14,431 and 11,324 eccDNAs were found in the ESRD and NC groups, respectively, with sizes ranging from 0.01 kb to 60 kb at most. Additionally, the ESRD group had a greater distribution of eccDNA on chromosomes 4, 11, 13, and 20. In two groups, we also discovered several motifs of specific eccDNAs. Furthermore, we identified 13,715 specific eccDNAs in the ESRD group and 10,585 specific eccDNAs in the NC group, both of which were largely annotated as mRNA catalog. Pathway studies using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) showed that the specific eccDNA in ESRD was markedly enriched in cell junction and communication pathways. Furthermore, we identified potentially 20 hub eccDNA-targeting genes from all ESRD-specific eccDNA-targeting genes. Also, we found that 39 eccDNA-targeting genes were associated with ESRD, and some of these eccDNAs may be related to the pathogenesis of ESRD.
Conclusions
Our findings revealed the characteristics of eccDNA in ESRD patients and discovered potentially hub and ESRD-relevant eccDNA-targeting genes, suggesting a novel probable mechanism of ESRD.
Funder
Guangzhou Development Zone entrepreneurship leading talent project
Key Renal Laboratory of Shenzhen
Shenzhen Fund for Guangdong Provincial High- level Clinical Key Specialties
The science and technology plan of Shenzhen
Guangxi Key Laboratory of Metabolic Diseases Research
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Johnson CA, Levey AS, Coresh J, Levin A, Eknoyan JG, et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
2. Wang J, Zhang L, Tang SC, Kashihara N, Kim YS, Togtokh A, et al. Disease burden and challenges of chronic kidney disease in North and East Asia. Kidney Int. 2018;94(1):22–5.
3. Zhang L, Wang J, Yang CW, Tang SC, Kashihara N, Kim YS, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia. Kidney Int Suppl. 2011;11(2):e77–85.
4. Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–6.
5. Malekmakan L, Tadayon T, Roozbeh J, Sayadi M. End-stage renal disease in the Middle East: a systematic review and meta-analysis. Iran J Kidney Dis. 2018;12(4):195–203.